Medicare Enrolled

Dr. Raul Santos, MD

Cardiovascular Disease · Grapevine, TX
Practice pattern: Cardiac & Electrophysiology— Practice combining cardiac and electrophysiology services
Low-engagement
1600 W COLLEGE ST, Grapevine, TX 76051
8179128400
In practice since 2006 (19 years)
NPI: 1013926039 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Santos from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Santos? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Santos

Dr. Raul Santos is a cardiovascular disease in Grapevine, TX, with 19 years in practice. Based on federal Medicare data, Dr. Santos performed 6,512 Medicare services across 4,948 unique beneficiaries.

Between the years covered by Open Payments, Dr. Santos received a total of $8,686 from 38 pharmaceutical and/or device companies across 495 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Santos is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 9% volume in TX$ $8,686 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,512
Medicare services
Top 9% in TX for cardiovascular disease
4,948
Unique beneficiaries
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~343 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Regadenoson injection (Lexiscan) for heart stress test1,020$43$223
Electrocardiogram (EKG), 12-lead882$10$51
Office visit, established patient (30-39 min)751$85$238
Office visit, established patient (20-29 min)577$58$168
Echocardiogram, transthoracic413$141$729
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician347$47$258
Technetium tc-99m tetrofosmin, diagnostic, per study dose323$54$525
Nuclear medicine studies of heart muscle at rest and with stress and spect321$325$1,599
Anticoagulant management of patient taking warfarin236$8$41
Prothrombin time test (blood clotting)196$4$26
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes126$9$128
New patient office visit (45-59 min)126$110$310
Blood draw (venipuncture)105$8$17
Initial hospital admission, moderate complexity86$99$352
Cardiac catheterization83$167$1,035
New patient office visit (30-44 min)77$72$207
Remote pacemaker/defibrillator monitoring, 90 days76$15$84
Ultrasound of both sides of head and neck blood flow71$134$704
Remote pacemaker monitoring, 90 days59$21$109
Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report57$159$858
Hospital follow-up visit, moderate complexity53$61$186
Heart rhythm recording of continous external ekg over 8-15 days50$9$96
Heart rhythm review and interpretation of continous external ekg over 8-15 days48$19$98
Coronary stent placement43$420$2,057
Injection, perflutren lipid microspheres, per ml42$34$390
Programming of dual lead pacemaker system30$52$299
Heart rhythm recording continous external ekg over more than 48 hours up to 7 days29$9$96
Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days28$17$98
Ultrasound study of arm and leg arteries28$48$299
Ultrasound of leg arteries or artery grafts26$178$891
Initial hospital admission, high complexity26$128$517
Ultrasound of heart with color-depicted blood flow, rate and valve function22$2$28
Ultrasound of heart with probe in esophagus, with report20$81$393
Ultrasound of heart blood flow, valves and chambers20$14$65
Hospital follow-up visit, high complexity20$88$268
Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist17$175$1,175
Office visit, established patient, complex (40-54 min)17$112$335
Telephone medical discussion with physician, 11-20 minutes16$43$212
Ultrasound of heart, follow-up15$73$361
Insertion of tube in coronary artery for diagnosis with review by radiologist15$148$841
Injection, aminophyllin, up to 250 mg15$5$13
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.7% high complexity
30.1% medium
58.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$8,686
Total received (2018-2024)
Avg $1,241/year across 7 years
Top 35% in TX for cardiovascular disease
38
Companies
495
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,686 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,682
2023
$1,114
2022
$1,152
2021
$1,213
2020
$627
2019
$1,072
2018
$1,825

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,087
PFIZER INC.
$808
Amgen Inc.
$718
Abbott Laboratories
$594
E.R. Squibb & Sons, L.L.C.
$510
Merck Sharp & Dohme LLC
$491
Boehringer Ingelheim Pharmaceuticals, Inc.
$478
HeartFlow, Inc.
$433
Janssen Pharmaceuticals, Inc
$399
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$388
AstraZeneca Pharmaceuticals LP
$376
SANOFI-AVENTIS U.S. LLC
$372
Gilead Sciences, Inc.
$262
Amarin Pharma Inc.
$190
Astellas Pharma US Inc
$177
ABIOMED
$171
Bayer HealthCare Pharmaceuticals Inc.
$149
Lundbeck LLC
$143
ARBOR PHARMACEUTICALS, INC.
$129
Esperion Therapeutics, Inc.
$127
SCPHARMACEUTICALS INC.
$94
CVRx, Inc.
$69
Boston Scientific Corporation
$64
Arbor Pharmaceuticals, Inc.
$59
Actelion Pharmaceuticals US, Inc.
$55
Medtronic, Inc.
$42
Alnylam Pharmaceuticals Inc.
$42
Allergan Inc.
$39
Philips Electronics North America Corporation
$31
Chiesi USA, Inc.
$30
AbbVie Inc.
$28
Novo Nordisk Inc
$25
BOSTON SCIENTIFIC CORPORATION
$25
Impulse Dynamics (USA) Inc.
$22
AGEPHA Pharma FZ LLC
$18
Philips North America LLC
$18
Medtronic Vascular, Inc.
$14
Kowa Pharmaceuticals America, Inc.
$12
Top 3 companies account for 30.1% of total payments
Associated products mentioned in payments ›
(5050) Extended Holter · (CK4) MCOT · Adempas · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CARDIOMEMS · CHANTIX · CONFIRM RX · CardioMEMS HF System · Claria MRI · Confirm Rx · Corlanor · ELIQUIS · ENTRESTO · Edarbi · Edarbyclor · FARXIGA · FFRct · FUROSCIX · HeartMate 3 Left Ventricular Assist Device · HeartMate 3 Left Ventricular Dev · Impella · JARDIANCE · KENGREAL · LATITUDE Communicator Power Supply · LEQVIO · LEXISCAN · LODOCO · LifeVest · Livalo · MULTAQ · NEXLETOL · NORTHERA · ONPATTRO · ONYX FRONTIER · OPSUMIT · Optimizer · PRADAXA · PRALUENT · Perclose ProGlide suture mediated closure system · RESONATE · Repatha · TEFLARO · Telescope · VERQUVO · VYNDAQEL · Vascepa · Verquvo · WATCHMAN Access System · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $133 per 100 Medicare services performed
Looking for a cardiovascular disease in Grapevine?
Compare cardiovascular diseases in the Grapevine area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
337
Per 100K population
15.8
County median income
$81,905
Nearest hospital
BAYLOR SCOTT & WHITE MEDICAL CENTER GRAPEVINE
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Santos is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 9% in TX), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Santos experienced with regadenoson injection (lexiscan) for heart stress test?
Based on Medicare claims data, Dr. Santos performed 1,020 regadenoson injection (lexiscan) for heart stress test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Santos receive payments from pharmaceutical companies?
Yes. Dr. Santos received a total of $8,686 from 38 companies across 495 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Santos's costs compare to other cardiovascular diseases in Grapevine?
Dr. Santos's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Santos) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →